- Title
- Changes in tumor blood flow as estimated by dynamic-contrast MRI may predict activity of single-agent bevacizumab in recurrent epithelial ovarian cancer and primary peritoneal cancer: An exploratory analysis of a Gynecologic Oncology Group phase II trial
- Creators
- D. Chase - University of California, Irvine Medical CenterM. Sill - Gynecologic Oncology GroupM. Chambers - VA Long Beach Healthcare SystemK. Darcy - Gynecologic Oncology GroupE. Han - City Of Hope National Medical CenterJ. Fruehauf - University of California, IrvineB. Monk - St. Joseph's Hospital and Medical CenterB. Buening - University of Washington Medical CenterJ. Sorosky - Hartford HospitalR. Burger - Fox Chase Cancer Center
- Publication Details
- Gynecologic oncology, Vol.120, pp.S65-S66
- Publisher
- Elsevier Inc
- Identifiers
- 991005968874802656
- Academic Unit
- Obstetrics & Gynecology
- Language
- English
- Resource Type
- Journal article
Journal article
Changes in tumor blood flow as estimated by dynamic-contrast MRI may predict activity of single-agent bevacizumab in recurrent epithelial ovarian cancer and primary peritoneal cancer: An exploratory analysis of a Gynecologic Oncology Group phase II trial
Gynecologic oncology, Vol.120, pp.S65-S66
03/01/2011
Metrics
4 Record Views